Conditional ablation of progesterone receptor membrane component 2 causes female premature reproductive senescence

Endocrinology

Volumn 158, Issue 3, 2017, Pages 640-651

  Clark, Nicole C ^a   Pru, Cindy A ^a   Yee, Siu Pok ^b   Lydon, John P ^c   Peluso, John J ^b   Pru, James K ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PGRMC1 PROTEIN, MOUSE; PGRMC2 PROTEIN, MOUSE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO DEATH; ENDOMETRIUM TUMOR; FEMALE; FEMALE INFERTILITY; FEMALE SUBFERTILITY; GENOTYPING TECHNIQUE; GYNECOLOGIC DISEASE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NIDATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREMATURE REPRODUCTIVE SENESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION; UTERUS TISSUE; ANIMAL; FERTILITY; GENETICS; MOUSE; OVARY; PATHOLOGY; PHYSIOLOGY; PREMATURE AGING; TRANSGENIC MOUSE; UTERUS;

AGING, PREMATURE; ANIMALS; EMBRYO LOSS; FEMALE; FERTILITY; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; OVARY; RECEPTORS, PROGESTERONE; UTERUS;

EID: 85014452079     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1701     Document Type: Article

References (66)

1. Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34(1):130-162.
2. Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab. 2011;22(4): 145-152.
3. Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L. Progesterone as an immunomodulatory molecule. Int Immunopharmacol. 2001;1(6):1037-1048.
4. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006;1(2):106-111.
5. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA, Giudice LC. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology. 2007;148(8): 3814-3826.
6. Ehn NL, Cooper ME, Orr K, Shi M, Johnson MK, Caprau D, Dagle J, Steffen K, Johnson K, Marazita ML, Merrill D, Murray JC. Evaluation of fetal and maternal genetic variation in the progesterone receptor gene for contributions to preterm birth. Pediatr Res. 2007;62(5):630-635.
7. Ito K, Utsunomiya H, Yaegashi N, Sasano H. Biological roles of estrogen and progesterone in human endometrial carcinoma: new developments in potential endocrine therapy for endometrial cancer. Endocr J. 2007;54(5):667-679.
8. Salazar EL, Calzada L. The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. Gynecol Endocrinol. 2007;23(4):222-225.
9. Boruban MC, Altundag K, Kilic GS, Blankstein J. From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures. Eur J Cancer Prev. 2008; 17(2):133-138.
10. Infertility. Available at: www.cdc.gov/nchs/fastats/infertility.htm. Accessed 23 September 2016.
11. Endometriosis: a guide for patients. American Society for Reproductive Medicine; 2012. Available at: www.asrm.org/booklet-endometriosis. Accessed 21 September 2016.
12. Tang YT, Hu T, Arterburn M, Boyle B, Bright JM, Emtage PC, Funk WD. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol. 2005;61(3):372-380.
13. Thomas P. Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol. 2008;29(2):292-312.
14. Pru JK, Clark NC. PGRMC1 and PGRMC2 in uterine physiology and disease. Front Neurosci. 2013;7:168.
15. Gerdes D, Wehling M, Leube B, Falkenstein E. Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem. 1998;379(7):907-911.
16. Chen C, Sargent C, Quilter C, Yang Z, Ren J, Affara N, Brenig B, Huang L. Cloning, mapping and molecular characterization of porcine progesterone receptor membrane component 2 (PGRMC2) gene. Genet Mol Biol. 2010;33(3):471-474.
17. Cahill MA. Progesterone receptor membrane component 1: an integrative review. J Steroid Biochem Mol Biol. 2007;105(1-5):16-36.
18. Peluso JJ, Pappalardo A, Losel R, Wehling M. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. Endocrinology. 2006;147(6):3133-3140.
19. Kowalik MK, Kotwica J. Progesterone receptor membrane component 1 (PGRMC1) gene expression in corpus luteum during the estrous cycle in cows. Reprod Biol. 2008;8(3):291-297.
20. Luciano AM, Corbani D, Lodde V, Tessaro I, Franciosi F, Peluso JJ, Modina S. Expression of progesterone receptor membrane component-1 in bovine reproductive system during estrous cycle. Eur J Histochem. 2011;55(3):e27.
21. Tahir MZ, Reynaud K, Mawa G, Thoumire S, Chastant-Maillard S, Saint-Dizier M. Immunolocalization of progesterone receptors in the canine oviduct around ovulation. Reprod Domest Anim. 2012; 47(Suppl 6):35-39.
22. Saint-Dizier M, Sandra O, Ployart S, Chebrout M, Constant F. Expression of nuclear progesterone receptor and progesterone receptor membrane components 1 and 2 in the oviduct of cyclic and pregnant cows during the post-ovulation period. Reprod Biol Endocrinol. 2012;10:76.
23. Luciano AM, Lodde V, Franciosi F, Ceciliani F, Peluso JJ. Progesterone receptor membrane component 1 expression and putative function in bovine oocyte maturation, fertilization, and early embryonic development. Reproduction. 2010;140(5):663-672.
24. Rambags BP, van Tol HT, van den Eng MM, Colenbrander B, Stout TA. Expression of progesterone and oestrogen receptors by early intrauterine equine conceptuses. Theriogenology. 2008;69(3): 366-375.
25. Kowalik MK, Slonina D, Rekawiecki R, Kotwica J. Expression of progesterone receptor membrane component (PGRMC) 1 and 2, serpine mRNA binding protein 1 (SERBP1) and nuclear progesterone receptor (PGR) in the bovine endometrium during the estrous cycle and the first trimester of pregnancy. Reprod Biol. 2013;13(1):15-23.
26. Slonina D, Kowalik MK, Kotwica J. Expression of progesterone receptor membrane component 1, serpine mRNA binding protein 1 and nuclear progesterone receptor isoforms A and B in the bovine myometrium during the estrous cycle and early pregnancy. J Reprod Dev. 2012;58(3):288-294.
27. Wu W, Shi SQ, Huang HJ, Balducci J, Garfield RE. Changes in PGRMC1, a potential progesterone receptor, in humanmyometrium during pregnancy and labour at termand preterm. Mol Hum Reprod. 2011;17(4):233-242.
28. Zhang L, Kanda Y, Roberts DJ, Ecker JL, Losel R, Wehling M, Peluso JJ, Pru JK. Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human. Mol Cell Endocrinol. 2008;287(1-2):81-89.
29. Feng L, Antczak BC, Lan L, Grotegut CA, Thompson JL, Allen TK, Murtha AP. Progesterone receptor membrane component 1 (PGRMC1) expression in fetal membranes among women with preterm premature rupture of the membranes (PPROM). Placenta. 2014;35(5):331-333.
30. McCallum ML, Pru CA, Niikura Y, Yee SP, Lydon JP, Peluso JJ, Pru JK. Conditional ablation of progesterone receptor membrane component 1 results in subfertility in the female and development of endometrial cysts. Endocrinology. 2016;157(9):3309-3319.
31. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG. Ahighly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001; 73(1):56-65.
32. Soyal SM, Mukherjee A, Lee KY, Li J, Li H, DeMayo FJ, Lydon JP. Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis. 2005;41(2):58-66.
33. Piekorz RP, Gingras S, Hoffmeyer A, Ihle JN, Weinstein Y. Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alphahydroxysteroid dehydrogenase. Mol Endocrinol. 2005;19(2): 431-440.
34. Lösel RM, Besong D, Peluso JJ, Wehling M. Progesterone receptor membrane component 1: many tasks for a versatile protein. Steroids. 2008;73(9-10):929-934.
35. Peluso JJ, Pru JK. Non-canonical progesterone signaling in granulosa cell function. Reproduction. 2014;147(5):R169-R178.
36. Liu L, Wang J, Zhao L, Nilsen J, McClure K, Wong K, Brinton RD. Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology. 2009;150(7):3186-3196.
37. Griffin D, Liu X, Pru C, Pru JK, Peluso JJ. Expression of progesterone receptor membrane component-2 within the immature rat ovary and its role in regulating mitosis and apoptosis of spontaneously immortalized granulosa cells. Biol Reprod. 2014;91(2):36.
38. Terzaghi L, Tessaro I, Raucci F, Merico V, Mazzini G, Garagna S, Zuccotti M, Franciosi F, Lodde V. PGRMC1 participates in late events of bovine granulosa cells mitosis and oocyte meiosis. Cell Cycle. 2016;15(15):2019-2032.
39. Luciano AM, Peluso JJ. PGRMC1 and the faithful progression through mitosis and meiosis. Cell Cycle. 2016;15(17):2239-2240.
40. Kimura I, Nakayama Y, Konishi M, Terasawa K, Ohta M, Itoh N, Fujimoto M. Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins. Curr Protein Pept Sci. 2012;13(7):687-696.
41. Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ, Espenshade PJ. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab. 2007;5(2):143-149.
42. Peluso JJ, Liu X, Gawkowska A, Lodde V, Wu CA. Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression. Mol Cell Endocrinol. 2010;320(1-2):153-161.
43. Peluso JJ, Lodde V, Liu X. Progesterone regulation of progesterone receptor membrane component 1 (PGRMC1) sumoylation and transcriptional activity in spontaneously immortalized granulosa cells. Endocrinology. 2012;153(8):3929-3939.
44. Swiatek-De Lange M, Stampfl A, Hauck SM, Zischka H, Gloeckner CJ, Deeg CA, Ueffing M. Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells. Glia. 2007;55(10):1061-1073.
45. Neubauer H, Adam G, Seeger H, Mueck AO, Solomayer E, Wallwiener D, Cahill MA, Fehm T. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells. Climacteric. 2009;12(3):230-239.
46. Maeda Y, Ohtsuka H, Tomioka M, Oikawa M. Effect of progesterone on Th1/Th2/Th17 and regulatory T cell-related genes in peripheral blood mononuclear cells during pregnancy in cows. Vet Res Commun. 2013;37(1):43-49.
47. Mir SU, Schwarze SR, Jin L, Zhang J, Friend W, Miriyala S, St Clair D, Craven RJ. Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy. Autophagy. 2013;9(10):1566-1578.
48. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, Sugase K, Shimamura T, Ohmura M, Muraoka K, Yamamoto A, Uchida T, Iwata S, Yamaguchi Y, Krayukhina E, Noda M, Handa H, Ishimori K, Uchiyama S, Kobayashi T, Suematsu M. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030.
49. Piel III RB, Shiferaw MT, Vashisht AA, Marcero JR, Praissman JL, Phillips JD, Wohlschlegel JA, Medlock AE. A novel role for progesterone receptor membrane component 1 (PGRMC1): A partner and regulator of ferrochelatase. Biochemistry. 2016;55(37): 5204-5217.
50. Bazer FW, Wu G, Johnson GA, Kim J, Song G. Uterine histotroph and conceptus development: select nutrients and secreted phosphoprotein 1 affect mechanistic target of rapamycin cell signaling in ewes. Biol Reprod. 2011;85(6):1094-1107.
51. Suchanek M, Radzikowska A, Thiele C. Photo-leucine and photomethionine allow identification of protein-protein interactions in living cells. Nat Methods. 2005;2(4):261-267.
52. Rohe HJ, Ahmed IS, Twist KE, Craven RJ.PGRMC1(progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding. Pharmacol Ther. 2009;121(1):14-19.
53. Hempstock J, Cindrova-Davies T, Jauniaux E, Burton GJ. Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study. Reprod Biol Endocrinol. 2004;2:58.
54. Ahmed IS, Rohe HJ, Twist KE, Craven RJ. Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. J Biol Chem. 2010;285(32):24775-24782.
55. Hampton KK, Craven RJ. Pathways driving the endocytosis of mutant and wild-type EGFR in cancer. Oncoscience. 2014;1(8): 504-512.
56. Aizen J, Thomas P. Role of Pgrmc1 in estrogen maintenance of meiotic arrest in zebrafish oocytes through Gper/Egfr. J Endocrinol. 2015;225(1):59-68.
57. Large MJ, Wetendorf M, Lanz RB, Hartig SM, Creighton CJ, Mancini MA, Kovanci E, Lee KF, Threadgill DW, Lydon JP, Jeong JW, DeMayo FJ. The epidermal growth factor receptor critically regulates endometrial function during early pregnancy. PLoS Genet. 2014;10(6):e1004451.
58. Kim M, Park HJ, Seol JW, Jang JY, Cho YS, Kim KR, Choi Y, Lydon JP, Demayo FJ, Shibuya M, Ferrara N, Sung HK, Nagy A, Alitalo K, Koh GY. VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. EMBO Mol Med. 2013;5(9):1415-1430.
59. García-Pascual CM, Ferrero H, Zimmermann RC, Simón C, Pellicer A, Gómez R. Inhibition of Delta-like 4 mediated signaling induces abortion in mice due to deregulation of decidual angiogenesis. Placenta. 2014;35(7):501-508.
60. Schumacher A, Costa SD, Zenclussen AC. Endocrine factors modulating immune responses in pregnancy. Front Immunol. 2014;5:196.
61. Krieg S, Westphal L. Immune function and recurrent pregnancy loss. Semin Reprod Med. 2015;33(4):305-312.
62. Kaluka D, Batabyal D, Chiang BY, Poulos TL, Yeh SR. Spectroscopic and mutagenesis studies of human PGRMC1. Biochemistry. 2015;54(8):1638-1647.
63. Falkenstein E, Heck M, Gerdes D, Grube D, Christ M, Weigel M, Buddhikot M, Meizel S, Wehling M. Specific progesterone binding to a membrane protein and related nongenomic effects on Ca2+-fluxes in sperm. Endocrinology. 1999;140(12):5999-6002.
64. Falkenstein E, Eisen C, Schmieding K, Krautkrämer M, Stein C, Lösel R, Wehling M. Chemical modification and structural analysis of the progesterone membrane binding protein from porcine liver membranes. Mol Cell Biochem. 2001;218(1-2):71-79.
65. Thomas P, Pang Y, Dong J. Enhancement of cell surface expression and receptor functions of membrane progestin receptor α (mPRα) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors. Endocrinology. 2014;155(3):1107-1119.
66. Mutter GL. Endometrial hyperplasia without atypia and EIN. In: Mutter GL, Prat J, eds. Pathology of the Female Reproductive Tract. 3rd ed. London, UK: Churchill Livingstone Elsevier; 2014.